Oxidative damage and cytogenetic analysis in leukocytes of Parkinson's disease patients

Neurology

Volumn 58, Issue 12, 2002, Pages 1809-1815

  Migliore, L ^a   Petrozzi, L ^a   Lucetti, C ^a   Gambaccini, G ^a   Bernardini, S ^a   Scarpato, R ^a   Trippi, F ^a   Barale, R ^a   Frenzilli, G ^a   Rodilla, V ^b   Bonuccelli, U ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSIDAD CEU CARDENAL HERRERA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; SINGLE STRANDED DNA;

ADULT; AGE; AGED; ARTICLE; CHROMOSOME; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DISEASE ASSOCIATION; DNA DAMAGE; DNA STRAND BREAKAGE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; LEUKOCYTE; LIPID PEROXIDATION; MALE; MICRONUCLEUS TEST; OXIDATION; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SMOKING HABIT; SUBSTANTIA NIGRA;

EID: 0037172827     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.58.12.1809     Document Type: Article

References (58)

1. The genetics of Parkinson's disease
2. Parkinson's disease, pesticides and mitochondrial dysfunction
3. The causes of Parkinson's disease are being unraveled and rational neuroprotective therapy is close to reality
4. Mitochondrial complex I deficiency in Parkinson's disease
5. Mitochondrial DNA analysis in Parkinson's disease
6. Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients
7. Reduced and oxidized glutathione in the substantia nigra of patients in Parkinson's disease
8. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia
9. Free radicals as mediators of neuronal injury
10. Oxidation of free amino acid residues in proteins by radiolysis and by metal catalysed reactions
11. Oxidative damage to DNA in mammalian chromatin
12. Mechanism of DNA oxidation
13. Free radicals, lipids and protein degradation
14. Normal oxidative damage to mitochondrial and nuclear DNA is extensive
15. Cancer risk and oxidative DNA damage in man
16. Instability and decay of the primary structure of DNA
17. Intermediate cancer biomarkers and their use in β-carotene studies in humans
18. Can antioxidant vitamins materially reduce oxidative damage in humans?
19. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones
20. Auto-oxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro
21. Parkinsonism: Onset progression and mortality
22. The cytokinesis-block micronucleus technique: A detailed description of the method and its application to genotoxicity studies in human populations
23. A simple technique for quantitation of low levels of DNA damage in individual cells
24. UV-C sensitivity of unstimulated and stimulated human lymphocytes from normal and xeroderma pigmentosum donors in the comet assay: A potential diagnostic technique
25. The Comet assay: Mechanisms and technical considerations
26. Direct enzymic detection of endogenous oxidative base damage in human lymphocyte DNA
27. Spontaneous and induced aneuploidy in peripheral blood lymphocytes of patients with Alzheimer's disease
28. Preferential occurrence of chromosome 21 malsegregation in peripheral blood lymphocytes of Alzheimer disease patients
29. Spontaneous and induced chromosome damage in somatic cells of sporadic and familial Alzheimer's disease patients
30. Prooxidant states and tumor promotion
31. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease
32. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease
33. A marker of oxyradical-mediated DNA damage (8-hydroxy-2′deoxyguanosine) is increased in nigro-striatum of Parkinson's disease brain
34. Oxidative DNA damage in the parkinsonian brain: An apparent selective increase in 8-hydroxyguanine levels in substantia nigra
35. Superoxide dismutase activity in early and advanced Parkinson's disease
36. Increased erythrocyte susceptibility to lipid peroxidation in human Parkinson's disease
37. Oxygen free radical producing activity in patients with Parkinson's disease
38. Abnormalities of the electron transport chain in idiopathic Parkinson's disease
39. Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease
40. Platelet mitochondrial function in Parkinson's disease
41. Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease
42. Mitochondrial oxidative phosphorylation defects in Parkinson's disease
43. Mitochondrial respiratory chain activity in skeletal muscle from patients with Parkinson's disease
44. Determination of hydroxyl free radical formation in human platelets using high-performance liquid chromatography with electrochemical detection
45. Oxidative damage to DNA in lymphocytes from AD patients
46. DNA damage in diabetes: Correlation with a clinical marker
47. Oxidative stress, antioxidants and human health
48. Platelet monoamine oxidase B activity in Parkinsonian patients
49. Mitochondrial dysfunction in Parkinson's disease
50. [3H] spiperone binding to lymphocytes in extrapyramidal disease and aging
51. Reduced dopamine in peripheral blood lymphocytes in Parkinson's disease
52. A review of xenobiotic metabolism enzymes in Parkinson's disease and motor neuron disease
53. Impaired oxidative decarboxylation of pyruvate in fibroblasts from patients with Parkinson's disease
54. Parkinson's disease: The presence of Lewy bodies in Auerbach's and Meissner's plexuses
55. Ataxia-telangiectasia: Is ATM a sensor of oxidative damage and stress?
56. Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs
57. Linking DNA damage and neurodegeneration
58. Recent advances in chromosome breakage syndromes and their diagnosis